Don't overlook Eli Lilly ... for its type 2 diabetes treatment, Mounjaro, and its anti-obesity drug, Zepbound. Lilly hopes to file for regulatory approvals of daily weight-loss pill orforglipron later ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.